WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke KRASLOQ wurde als Wortmarke am 17.03.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1589762 |
| Länder | 
|
| Basismarke |
Nr. 90238399,
06. Oktober 2020
|
| Anmeldedatum | 17. März 2021 |
| Ablaufdatum | 17. März 2031 |
Markeninhaber
3545 Cray Court
San Diego CA 92121
US
San Diego CA 92121
US
Markenvertreter
300 South Wacker Drive, 31st Floor
Chicago IL 60606
US
Waren und Dienstleistungen
05
Pharmaceuticals; pharmaceutical preparations; pharmaceutical
products; pharmaceutical preparations for the treatment of
cancer; pharmaceutical preparations for use in oncology;
pharmaceutical preparations for the treatment of infectious
diseases; pharmaceutical preparations for the treatment of
lung cancer; pharmaceutical preparations for the treatment
of non-small cell lung carcinoma; pharmaceutical
preparations for the treatment of colorectal carcinoma;
pharmaceutical preparations for the treatment of pancreatic
cancer; pharmaceuticals comprising small molecules;
pharmaceuticals comprising small molecules for the treatment
of cancer; pharmaceuticals comprising small molecules for
the treatment of infectious diseases; pharmaceuticals
comprising small molecules for the treatment of lung cancer;
pharmaceuticals comprising small molecules for the treatment
of non-small cell lung carcinoma; pharmaceuticals comprising
small molecules for the treatment of colorectal carcinoma;
pharmaceuticals comprising small molecules for the treatment
of pancreatic cancer; pharmaceuticals comprising compounds;
pharmaceuticals comprising compounds for the treatment of
cancer; pharmaceuticals comprising inhibitors;
pharmaceuticals comprising inhibitors for the treatment of
cancer; pharmaceuticals for the treatment of solid tumors;
pharmaceuticals for the treatment of advanced solid tumors
42
Research and development of pharmaceuticals in the field of
oncology; providing information in the field of scientific
and medical research related to oncology; research and
development of pharmaceuticals; providing information in the
field of scientific and medical research related to
pharmaceuticals
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 11. Oktober 2022 | 2022/41 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 07. Juli 2022 | 2022/27 Gaz | MX | Ablehnung |
| 03. Mai 2022 | 2022/22 Gaz | BR | Ablehnung |
| 03. Mai 2022 | 2022/39 Gaz | BR | RAW: Second Part Fee Not Paid |
| 11. April 2022 | 2022/17 Gaz | CH | Ablehnung |
| 10. März 2022 | 2023/30 Gaz | JP | RAW: Second Part Fee Not Paid |
| 10. März 2022 | 2022/10 Gaz | JP | Ablehnung |
| 20. Januar 2022 | 2022/3 Gaz | KR | Ablehnung |
| 30. November 2021 | 2021/48 Gaz | NZ | Ablehnung |
| 16. November 2021 | 2021/46 Gaz | IN | Ablehnung |
| 26. Juli 2021 | 2021/30 Gaz | RU | Ablehnung |
| 17. März 2021 | 2021/16 Gaz | US | Eintragung |
ID: 141589762